Topics

Belgian firm to acquire Ra Pharmaceuticals for $2.1B

06:35 EDT 11 Oct 2019 | SmartBrief

UCB of Belgium announced plans to acquire Ra Pharmaceuticals in a deal worth $2.1 billion.  -More

Original Article: Belgian firm to acquire Ra Pharmaceuticals for $2.1B

NEXT ARTICLE

More From BioPortfolio on "Belgian firm to acquire Ra Pharmaceuticals for $2.1B"

Quick Search

Relevant Topic

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...